Congratulations!
09.10.2025 15:42 — 👍 1 🔁 0 💬 0 📌 0
YouTube video by EORTC
Meet the EORTC Early Career Investigators
On #ClinicalTrialsDay, meet the next generation driving #CancerResearch forward. 👩🏻⚕️
In this video, Ioannis, Jens, and Antonella share what it means to be part of the EORTC Early Career Investigator community.
Learn more: www.eortc.org/blog/2025/05...
▶️ youtu.be/cjPQDCxrZbI
20.05.2025 09:29 — 👍 3 🔁 3 💬 0 📌 0
Wow! Really interesting work. Congratulations
12.05.2025 13:07 — 👍 2 🔁 0 💬 0 📌 0
Please have a look at our comment on #ICI and #TKI for unresectable #HCC published in @thelancetoncol.bsky.social @acammarota.bsky.social
09.05.2025 22:55 — 👍 2 🔁 1 💬 0 📌 0
"Science is a career for anyone curious enough to ask why, and stubborn enough to keep on asking." Yes, love this
03.02.2025 07:28 — 👍 17 🔁 6 💬 0 📌 0
Only a subset of patients respond to immunotherapy
Why? Which ones?
We conducted an unbiased analysis of response biomarkers and found that hundreds of possible biomarkers collapse into five latent, orthogonal factors that underlie immunotherapy response.
www.nature.com/articles/s41...
27.11.2024 14:13 — 👍 132 🔁 47 💬 4 📌 5
Thanks, Lizzy! Looking forward to more works together ☺️
29.11.2024 10:23 — 👍 1 🔁 0 💬 1 📌 0
Based in the Department of Oncology at the MRC WIMM, University of Oxford | We study the genetics of immunity with a focus on the determinants of response to cancer immunotherapy.
Genetics, immunology, oncology, science.
Cooperative and interdisciplinary network of European multi-stakeholders aiming to implement precision medicine in the management of #BiliaryCancer #COST
Liver pathologist in Edinburgh, looking for patterns on glass. Luton Town fan, hoping for beauty on grass. 🔬
Tea addict and scientist, in that order. Incoming Group Leader, Dept of Oncology, University of Oxford. All views my own.
Research scientist interested in #OncoImmunology
Assistant Professor @Hunimed
Junior Group Leader @HumanitasMilano
Website: https://www.humanitas-research.org/groups/eduardo-bonavita-group/
M.D. - Medical Oncology Resident at the University Hospital of Pisa (Italy), focused on clinical and translational research on gastrointestinal cancers
We define better treatments for all cancer patients to prolong survival and improve quality of life.
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
We study the drivers of cancer evolution from initiation to response to therapy. We are part of the Centre for Cancer Evolution at Barts Cancer Institute and the Francis Crick Institute in London, UK. Posts from Francesca
An educator and an oncologist.
Consultant MedOnc, YOC member @myESMO, co-chair of postgrad com @AMEE_Online and many other 🎩. 🇪🇪/🇪🇺 in🇬🇧
Research group leader at the Early Cancer Institute in Cambridge studying somatic evolution using longitudinal non-invasive samples such as circulating tumour DNA
Nature Genetics is a monthly journal publishing high impact research in genetics and genomics. Part of @natureportfolio.bsky.social
Repost/like=interesting/relevant, not necessarily endorsement.
Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823.
🌐 thelancet.com
EMBL's European Bioinformatics Institute (EMBL-EBI) provides open biological data resources and tools, and performs basic research in computational biology. https://www.ebi.ac.uk/
Associate Professor of Medical Oncology at HUNIMED, GI cancer specialist with research interest in #livercancer, #HCC, #biliarytractcancer, #cholangiocarcinoma
Focused on innate immune mechanisms governing pathogenesis of disease and on NK-cell based therapies for disease. Opinions expressed are Dr. Waggoner's alone and not on behalf of lab staff or employer.
GI oncologist at UZ Leuven, Belgium
